Author
Listed:
- Feng Ma
(Immunology, and Molecular Genetics, University of California)
- Su-Yang Liu
(Immunology, and Molecular Genetics, University of California)
- Bahram Razani
(Immunology, and Molecular Genetics, University of California)
- Neda Arora
(Immunology, and Molecular Genetics, University of California)
- Bing Li
(University of California)
- Hiroyuki Kagechika
(Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University)
- Peter Tontonoz
(Howard Hughes Medical Institute
University of California)
- Vanessa Núñez
(Centro Nacional de Investigaciones Cardiovasculares (CNIC))
- Mercedes Ricote
(Centro Nacional de Investigaciones Cardiovasculares (CNIC))
- Genhong Cheng
(Immunology, and Molecular Genetics, University of California)
Abstract
The retinoid X receptor α (RXRα), a key nuclear receptor in metabolic processes, is downregulated during host antiviral response. However, the roles of RXRα in host antiviral response are unknown. Here we show that RXRα overexpression or ligand activation increases host susceptibility to viral infections in vitro and in vivo, while Rxra−/− or antagonist treatment reduces infection by the same viruses. Consistent with these functional studies, ligand activation of RXR inhibits the expression of antiviral genes including type I interferon (IFN) and Rxra−/− macrophages produce more IFNβ than WT macrophages in response to polyI:C stimulation. Further results indicate that ligand activation of RXR suppresses the nuclear translocation of β-catenin, a co-activator of IFNβ enhanceosome. Thus, our studies have uncovered a novel RXR-dependent innate immune regulatory pathway, suggesting that the downregulation of RXR expression or RXR antagonist treatment benefits host antiviral response, whereas RXR agonist treatment may increase the risk of viral infections.
Suggested Citation
Feng Ma & Su-Yang Liu & Bahram Razani & Neda Arora & Bing Li & Hiroyuki Kagechika & Peter Tontonoz & Vanessa Núñez & Mercedes Ricote & Genhong Cheng, 2014.
"Retinoid X receptor α attenuates host antiviral response by suppressing type I interferon,"
Nature Communications, Nature, vol. 5(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6494
DOI: 10.1038/ncomms6494
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms6494. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.